Pfizer Plans Biologics Clinical Manufacturing Plant In Andover, Massachusetts
“The expansion of Pfizer’s presence in Andover will provide state-of-the-art manufacturing to help bring new medicines and vaccines to the patients we serve,” said John Ludwig, Senior Vice President, BioTherapeutics Pharmaceutical Sciences in Pfizer R&D. “Andover is a crucial part of our global footprint for both clinical and commercial manufacturing, and we believe it provides an attractive location for growth in the coming years.”
Earlier this year, Andover officials approved $2.9 million in tax incentives for the Pfizer project. The town’s Board of Selectmen, Planning Board and Finance Committee all recommended the five-year Tax-Increment Financing plan.
“Pfizer’s decision to expand their campus in Andover speaks to the Commonwealth’s continued global leadership in biopharma and our administration’s support of the growing advanced manufacturing sector,” said Massachusetts’ Lieutenant Governor Karyn Polito. “We are pleased to have Pfizer operating in Andover, Boston and Cambridge and look forward to their ongoing contributions to the Massachusetts’s economy and wellbeing of our citizens.”
2022 Top States for Doing Business Provide an Environment for Business Growth
Location Factors in the EV Industry — “Mission Critical” or “Nice to Have”?
2022 Auto/Aero Site Guide
Three Big Challenges Facing the Food & Beverage Industry
How Are Economic Developers Partnering to Solve Workforce Challenges?
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Fixing the Supply Chain with AI and Robotics
18th Annual Consultants Survey: Access to Major Markets and Skilled Labor Are Clients’ Primary Concerns